Literature DB >> 33164623

The possible role of Sirtuins and microRNAs in hepatocellular carcinoma therapy.

Hedyieh Karbasforooshan1, A Wallace Hayes2,3, Nooshin Mohammadzadeh4, Mohammad Reza Zirak5, Gholamreza Karimi5,6.   

Abstract

Hepatocellular carcinoma (HCC) is the most common primary liver cancer. Sirtuins are NAD+-dependent histone deacetylases that regulate many cellular processes such as proliferation, apoptosis, and metabolism. SIRT (silent information regulator)-1, 5, 6 and 7, members of the mammalian Sirtuin family of proteins (SIRT1-SIRT7), are involved in carcinogenesis, prognosis, metastasis, and chemical resistant of HCC. These proteins act through the deacetylation of tumor suppressor or oncogenic factors. MicroRNAs (miRNAs) are a group of small non-coding RNAs that down regulate gene expression by targeting the 3'-untranslated region of miRNAs. MiRNAs can function as tumor suppressors or as oncogenes and are involved in progression, differentiation, apoptosis and drug resistance of tumor cells. The focus of this review is to delineate the relationship between some microRNAs and their target, Sirtuins, and to present an overview of their function in HCC as currently understood.

Entities:  

Keywords:  Sirtuin; hepatocellular carcinoma; invasion; micrornas; proliferation

Year:  2020        PMID: 33164623      PMCID: PMC7751631          DOI: 10.1080/15384101.2020.1843813

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  69 in total

Review 1.  The role of monoacylglycerol lipase (MAGL) in the cancer progress.

Authors:  Hong Qin; Zhi-hua Ruan
Journal:  Cell Biochem Biophys       Date:  2014-09       Impact factor: 2.194

Review 2.  SIRT1 and microRNAs: The role in breast, lung and prostate cancers.

Authors:  Hedyieh Karbasforooshan; Ali Roohbakhsh; Gholamreza Karimi
Journal:  Exp Cell Res       Date:  2018-03-21       Impact factor: 3.905

3.  MicroRNA-449 suppresses proliferation of hepatoma cell lines through blockade lipid metabolic pathway related to SIRT1.

Authors:  Hongyi Zhang; Zhiqiang Feng; Rui Huang; Zhenglin Xia; Guoan Xiang; Jinqian Zhang
Journal:  Int J Oncol       Date:  2014-08-13       Impact factor: 5.650

4.  MicroRNAs: Processing, Maturation, Target Recognition and Regulatory Functions.

Authors:  Girish C Shukla; Jagjit Singh; Sailen Barik
Journal:  Mol Cell Pharmacol       Date:  2011

5.  Metabolic reprogramming enables hepatocarcinoma cells to efficiently adapt and survive to a nutrient-restricted microenvironment.

Authors:  Shamir Cassim; Valérie-Ann Raymond; Layla Dehbidi-Assadzadeh; Pascal Lapierre; Marc Bilodeau
Journal:  Cell Cycle       Date:  2018-05-21       Impact factor: 4.534

6.  Involvement of miRNA-29a in epigenetic regulation of transforming growth factor-β-induced epithelial-mesenchymal transition in hepatocellular carcinoma.

Authors:  Takayuki Kogure; Yasuteru Kondo; Eiji Kakazu; Masashi Ninomiya; Osamu Kimura; Tooru Shimosegawa
Journal:  Hepatol Res       Date:  2013-07-21       Impact factor: 4.288

7.  MiR-138 induces cell cycle arrest by targeting cyclin D3 in hepatocellular carcinoma.

Authors:  Wen Wang; Lan-Juan Zhao; Ye-Xiong Tan; Hao Ren; Zhong-Tian Qi
Journal:  Carcinogenesis       Date:  2012-02-23       Impact factor: 4.944

8.  The role of microRNA-133b and its target gene FSCN1 in gastric cancer.

Authors:  Lihua Guo; Hua Bai; Dongling Zou; Tao Hong; Jie Liu; Jiaqiang Huang; Pengfei He; Qi Zhou; Jinsheng He
Journal:  J Exp Clin Cancer Res       Date:  2014-11-30

9.  Notch1 signaling in melanoma cells promoted tumor-induced immunosuppression via upregulation of TGF-β1.

Authors:  Zike Yang; Yanxia Qi; Nan Lai; Jiahe Zhang; Zehong Chen; Mingyu Liu; Wan Zhang; Rongcheng Luo; Shijun Kang
Journal:  J Exp Clin Cancer Res       Date:  2018-01-04

10.  Waltonitone inhibits proliferation of hepatoma cells and tumorigenesis via FXR-miR-22-CCNA2 signaling pathway.

Authors:  Fan Yang; Junting Gong; Guangyun Wang; Peng Chen; Li Yang; Zhengtao Wang
Journal:  Oncotarget       Date:  2016-11-15
View more
  2 in total

Review 1.  Biochemical Mechanisms of Sirtuin-Directed Protein Acylation in Hepatic Pathologies of Mitochondrial Dysfunction.

Authors:  Courtney D McGinnis; Erin Q Jennings; Peter S Harris; James J Galligan; Kristofer S Fritz
Journal:  Cells       Date:  2022-06-28       Impact factor: 7.666

Review 2.  Inflammation suppression in doxorubicin-induced cardiotoxicity: natural compounds as therapeutic options.

Authors:  Fatemeh Yarmohammadi; Hedyieh Karbasforooshan; A Wallace Hayes; Gholamreza Karimi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2021-08-05       Impact factor: 3.000

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.